Cancer prevalence in humans
Pro Research Analysisby 
Searched over 200M research papers
Global Cancer Prevalence: Key Statistics and Trends
Worldwide Cancer Prevalence Estimates
Globally, cancer prevalence is substantial and continues to rise. In 2008, the estimated 5-year global cancer prevalence was 28.8 million people, with nearly half of this burden found in regions with very high human development, even though these areas only make up about one-sixth of the world’s population. The most prevalent cancers vary by region: breast cancer is the most common in most countries, while cervix, prostate, stomach, and oral cancers dominate in specific regions such as Sub-Saharan Africa, North America, Eastern Asia, and India, respectively.
Regional Differences in Cancer Prevalence
Cancer prevalence is highest in developed countries, with North America reporting about 1.5% of its population affected and diagnosed within the previous five years, followed by Western Europe and Australia/New Zealand at 1.2% and 1.1%, respectively. In contrast, prevalence in developing regions is much lower, around 0.2% to 0.4%. These differences are influenced by higher incidence rates, better survival, and longer life expectancy in wealthier countries248. In Europe, prevalence rates can range from 1,170 per 100,000 in some Eastern European countries to over 3,000 per 100,000 in parts of Scandinavia48.
Cancer Prevalence in Specific Countries
- United States: As of January 2019, more than 16.9 million Americans were living with a history of cancer, projected to exceed 22.1 million by 2030. The most prevalent cancers are prostate, colorectal, and melanoma in men, and breast, uterine, and colorectal in women. Most survivors (64%) are aged 65 or older.
- Canada: At the start of 2018, over 1.5 million Canadians were living with or beyond cancer, with about 60% diagnosed 5 to 25 years prior.
- Europe: In 2020, about 23.7 million people (5% of the population) were estimated to be alive after a cancer diagnosis, with breast and colorectal cancers most common in women, and prostate and colorectal cancers in men. The number of prevalent cases increased by 3.5% per year from 2010 to 2020, largely due to an aging population84.
- Korea: In 2021, over 2.4 million people were living with cancer, with a 5-year relative survival rate of 72.1%. The number of new cases and survivors has increased over time, reflecting improved survival and expanded cancer registration910.
Factors Influencing Cancer Prevalence
Cancer prevalence is shaped by several factors:
- Incidence and Survival: Higher incidence and better survival rates increase prevalence, especially in high-income countries248.
- Aging Population: As populations age, the number of people living with cancer rises, even if incidence rates stabilize or decline589.
- Economic Development: Wealthier regions tend to have higher prevalence due to better healthcare, longer survival, and more comprehensive cancer registration48.
- Cancer Type Distribution: The most prevalent cancers differ by region, influenced by local risk factors, screening practices, and healthcare access1489.
Future Projections and Prevention
Cancer prevalence is expected to continue rising globally, particularly in low- and middle-income countries as their populations age and grow. Without significant improvements in prevention, the global cancer burden could double by 2070. Effective prevention strategies—such as reducing tobacco use, addressing obesity, and increasing vaccination against cancer-causing infections—could help curb future increases in cancer prevalence.
Conclusion
Cancer prevalence in humans is high and increasing worldwide, especially in developed regions with aging populations and improved survival rates. The most common cancers vary by region, and the overall burden is expected to grow in the coming decades. These trends highlight the need for robust cancer control strategies, including prevention, early detection, and long-term care for survivors1245+5 MORE.
Sources and full results
Most relevant research papers on this topic